And I do - hope for somehing much better. A change to some form of marketing approval in lieu of REDUCE-IT results gives us $12-$24 a share overnight. Hellz2theyeah I'm hoping for better.
Here's a preview for you: From the offices of Mr. Jenkins. "While we think very highly of the applicant, and admire the efforts they've undertaken with a treatment that certainly has clinical benefit, we are unable to grant Amarin's petition for a reversal of our previous decision. The risks associated with this larger population of patients remains too large to roll the dice on a product that hasn't demonstrated event risk reduction. We do, however, eagerly await the results of REDUCE-IT (so we can tank those too).
Why do you think HR is understating their value kennedyj69? Like you, I'm outraged. It's almost as if he wants the stock to tank. These assets are worth significantly more and I thank you for pointing this out.
Discovered on Seeking Alpha that the trial had no issues through 3000 enrollees. Allergic reactions occurred following expansion of the treatment population. This could result in a trial restart but back to the original enrollment criteria.
Strange then that you went on to the CLDX Yahoo Message board with two short posts. You're pathological jk.
You're probably right. Needless to say, like Gatsby, some people want the price to always go up and never down. I'm confidently loading shares.
This is my first response to this kind of question. You're obviously a short masquerading as a disgruntled long. Very transparent. Learn the art of subtelety and you'll do better. Not much better. But better.
You can't get pure epa only online. You can get weighted versions than emphasize epa over dha but you can't get a month's supply under prescription for $9.